Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
Clinical trial NCT01853631 · RECRUITING
Trial details
- NCT number
- NCT01853631
- Sponsor
- Baylor College of Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2026-12-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.